Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 25 recruiting now later-stage tilt

Infertility: later-stage trial registry

25 of 75 indexed Infertility trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #178 of 28,707 conditions by registered trial count.

75 US clinical trials · 25 currently recruiting · #178 of 28,707 conditions by registered trial count

Infertility: 75 US clinical trials tracked, 25 recruiting.

Infertility is the subject of 75 registered US clinical trials on ClinicalTrials.gov, 25 of them currently open to new participants. 12 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is Reproductive Medicine Associates of New Jersey, running 6 of these trials.

Enrollment posture brief

Registry condition infertility

OPEN 25 | RECR 33% | LATE 12 | EARLY 5 | RANK #178 | SPON 6

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Acute Kidney Injury44%Infertility (this)33%Age-related Macular Degenera26.7%Tobacco Use Disorder25.3%Pulmonary Disease, Chronic O9.3%
Open-enrollment share among volume-matched conditions near Infertility

Infertility lists 25 open slots (33% of 75 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Infertility on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Infertility is recruiting below its size-band peers.

    25 of 75 indexed trials (33.3%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Infertility trials is spread across many organizations.

    Reproductive Medicine Associates of New Jersey accounts for 6 of 75 trials (8%). 49 distinct sponsors appear on at least one study for this condition label.

  3. Typical Infertility enrolment sits around 250 participants.

    Median target enrolment is 250 among the 75 trials that report a genuine target (sentinel values excluded). 21 of those (28%) plan for fewer than 100 participants.

  4. Infertility splits between interventional and observational designs.

    52 interventional and 23 observational studies make up this index (69.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 13Phase 22Phase 36Phase 46

Open and recent trials

75 total, page 2 of 2

COMPLETED Phase 3 405 participants

Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART)

Ferring Pharmaceuticals

NCT04163458

COMPLETED NA 393 participants

Sperm Selection by Microfluidic Separation Improves Embryo Quality

University of California, San Francisco

NCT03085433

COMPLETED 335 participants

Salivary Diagnostic Testing for IVF

Boston IVF

NCT02040545

COMPLETED NA 309 participants

Next Generation Sequencing Screening for Embryonic Ploidy Status

Reproductive Medicine Associates of New Jersey

NCT02032264

COMPLETED NA 264 participants

Communication With in Vitro Fertilization (IVF) Patients About Risks

University of Kansas Medical Center

NCT00722618

COMPLETED Phase 4 232 participants

Concomitant Administration of FSH With HCG Improves Oocyte Maturation and Quality Double -Blinded Randomized Trial

University of California, San Francisco

NCT00854373

COMPLETED NA 164 participants

Evaluation of Patient Experience and Quality of Life During In Vitro Fertilization Treatment

University of Michigan

NCT03383848

COMPLETED NA 140 participants

Comparison of Transfers of Thawed Blastocysts Versus Blastocysts Derived From Thawed Bipronuclear Oocytes

Bruce Shapiro M.D.

NCT01247987

COMPLETED NA 130 participants

GnRH Antagonist to Prepare Recipients for Embryo Transfer

Institute for Human Reproduction (IHR)

NCT00460642

COMPLETED Phase 4 122 participants

Menopur Mixed Protocol

Ferring Pharmaceuticals

NCT01417195

COMPLETED Phase 2 120 participants

Benefits of Walnuts for Male Reproductive Health

University of California, Los Angeles

NCT01505140

COMPLETED 81 participants

KIDScore D3 Clinical Study

Vitrolife

NCT03740828

COMPLETED NA 80 participants

Effectiveness of Web-based Teaching to Traditional Patient Education in the Use of Injectable Fertility Medications

Wake Forest University Health Sciences

NCT02420964

COMPLETED NA 79 participants

Evaluation of Ovarian Morphology and Function in Overweight Women During Weight Loss

Cornell University

NCT01785719

COMPLETED NA 71 participants

Online Mind/Body Program for Fertility

University of Vermont

NCT03343405

COMPLETED NA 60 participants

Evaluation of the Impact of Reduced Oxygen Concentration on Embryonic Development

Reproductive Medicine Associates of New Jersey

NCT02919384

COMPLETED Phase 1 60 participants

The Effect of Acupuncture on Infertility With In-Vitro Fertilization (IVF) Patients

National Center for Complementary and Integrative Health (NCCIH)

NCT00317317

COMPLETED NA 60 participants

Effect of Acupuncture on Vascular Biomarkers and Psychological Well-Being of Women Undergoing IVF

Texas Tech University Health Sciences Center

NCT02591186

COMPLETED Phase 3 40 participants

Vaginal Culture Using INVOcell Compared to Traditional IVF Incubation

Invaron Pharmaceuticals

NCT02363426

COMPLETED Phase 4 37 participants

Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF

Colorado Center for Reproductive Medicine

NCT00621179

COMPLETED 31 participants

Eeva™ Continued Access Study: Assessing the Usability of Eeva in a Clinical Setting

Progyny

NCT01617993

COMPLETED NA 30 participants

Estrogen Sensitivity and Ovulatory Dysfunction in Obesity

University of Colorado, Denver

NCT01381016

COMPLETED NA 27 participants

Oocyte Survival After Vitrification With Slush Nitrogen Compared With Liquid Nitrogen

Reproductive Medicine Associates of New Jersey

NCT04342364

COMPLETED 17 participants

Oocyte Cryopreservation Comparing Fresh and Vitrified Sibling Oocytes

UConn Health

NCT00986687

COMPLETED 6 participants

Embryo DNA Repair Capacity Project

Reproductive Medicine Associates of New Jersey

NCT03953859

← Previous Page 2 of 2

Phase Distribution

PhaseTrial count
Phase 1 3
Phase 2 2
Phase 3 6
Phase 4 6

Named interventions

Most-linked intervention names on Infertility records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

GnRH Drug
2 trials
Acupuncture Procedure
2 trials
Letrozole Drug
2 trials
Recombinant human chorionic gonadotropin (r-hCG) Drug
1 trials
Follitropin alfa 150 international unit (IU) Drug
1 trials
AS900672-Enriched 150 mcg Drug
1 trials
AS900672-Enriched 100 mcg Drug
1 trials
AS900672-Enriched 50 microgram (mcg) Drug
1 trials

US sites by state

Facility locations filed on Infertility trials. A trial with sites in several states counts in each.

California 15 trials
New Jersey 12 trials
Maryland 10 trials
Massachusetts 9 trials
Colorado 9 trials
Texas 8 trials
Pennsylvania 7 trials
New York 7 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Infertility page

75 registered trials, 25 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Infertility condition card totals 75 registered trials; most-linked intervention GnRH; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.